We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
-14.61%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
AUM
$273M
AUM Growth
-$74.8M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNGX icon
1
Tango Therapeutics
TNGX
$4.43B
$147M 53.77%
19,363,975
FULC icon
2
Fulcrum Therapeutics
FULC
$273M
$55.4M 20.3%
2,343,154
RVMD icon
3
Revolution Medicines
RVMD
$39.9B
$36.2M 13.27%
1,419,900
DNTH icon
4
Dianthus Therapeutics
DNTH
$5.84B
$19.6M 7.18%
422,388
PLRX icon
5
Pliant Therapeutics
PLRX
$64.4M
$15M 5.48%
2,132,867

Similar funds

TRV GP IV's Q1 2022 Portfolio in Review

As of Q1 2022, TRV GP IV held 5 positions worth $273M, down 22% from $348M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. TRV GP IV opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's ten largest holdings make up 100% of its $273M portfolio in Q1 2022.
  • TRV GP IV opened 0 new positions and closed 0 in Q1 2022.
  • TRV GP IV's portfolio value fell 22% quarter-over-quarter to $273M.

Based on TRV GP IV's 13F filing for Q1 2022, filed 10 May 2022.